Boston Scientific Initiates Global Study To Assess EMBLEM Subcutaneous Implantable Defibrillator In Primary Prevention Patients With Low Ejection Fraction
June 22, 2015 at 09:03 AM EDT
Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the ...